Found 5 matching trials
Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma PHASE1 This phase I/II trial tests the safety, side effects, and best dose of PLX2...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome PHASE1 The purpose of this research study is to evaluate safety, pharmacokinetics,...
Show More Location
Northside Hospital
Learn More & Join Trial
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer PHASE1 The purpose of this research study is to evaluate safety, pharmacokinetics,...
Show More Location
The University of Chicago Medical Center
Learn More & Join Trial
PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) PHASE1 The purpose of this research study is to evaluate safety, pharmacokinetics,...
Show More Location
University of Chicago
Learn More & Join Trial
A Study of PLX2853 in Advanced Malignancies. PHASE1 The purpose of this research study is to evaluate safety, pharmacokinetics,...
Show More Learn More & Join Trial